SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Marketstrat, Inc. | PRODUCT CODE: 2145377

Cover Image

PUBLISHER: Marketstrat, Inc. | PRODUCT CODE: 2145377

Global Enterprise Imaging IT & PACS Horizon: Market Structure, Forecasts, Competitive Dynamics, and Workflow Monetization, 2025A-2036E

PUBLISHED:
PAGES: 198 Pages; 97 Tables; 34 Figures
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Individual License)
USD 4950
PDF (Team License)
USD 5450
PDF (Enterprise License)
USD 8950

Add to Cart

Report Overview

This Marketstrat® Horizon Report analyzes the global enterprise imaging IT and picture archiving and communication systems (PACS) market from 2025 through 2036. It sizes and forecasts the software and directly attached services behind diagnostic viewing, image archiving, standalone RIS, radiology reporting, reader workflow, image exchange and patient access, and retained AI orchestration and governance.

The report ties the forecast to the decisions that set commercial outcomes: which application a customer replaces first, how a supplier earns additional scope, when contracted work becomes productive, and which payments survive renewal. Our view is that a first reader-platform award can open the way to later archive, reporting or workflow decisions, but a durable business still depends on accepted delivery and sustained payment. Independent suppliers need a continuing cross-system, service or specialized role as the customer's application environment changes.

Key Questions Answered

  • How does the first platform award shape the next purchase, and what should buyers settle on follow-on pricing, data access and exit terms at that first award?
  • What does a larger recurring contract actually represent once newly paid functionality, payments transferred from another supplier, and operating work moved into a managed service are separated?
  • Where can AI-assisted reporting and orchestration earn durable payment after substitution of earlier fees?
  • How should commercial strategy differ by country and by buyer type, from enterprise health systems to radiology groups and public imaging networks?
  • Which operating conditions separate the Base, Bull and Bear scenarios, and which signals should change the outlook?

Market Snapshot

The market is defined as external vendor revenue for common imaging applications and directly attached services, including vendor-bundled managed hosting. Clinical AI algorithms, dedicated specialty analytics, scanners and hardware, modality workstations, general EHR, professional interpretation and directly provider-paid infrastructure are excluded. Functional, revenue-recognition and geographic views describe the same revenue and reconcile to one defined total.

Growth depends on more than clinical demand. The forecast rests materially on the transition from legacy license economics to recurring contracts and on additional paid applications, alongside imaging activity, paid coverage and pricing. Because vendor receipts can rise when hosting moves into the contract or when one supplier absorbs another's fees, the report distinguishes growth in vendor revenue from net expansion in health-system spending.

Key Market Trends

  • 1. Core viewing and archives remain the commercial foundation. PACS and archive decisions carry the largest absolute opportunity, which keeps performance, interoperability, migration and support commercially consequential.
  • 2. Reporting brings more competitors into the reader's day. Established reporting suppliers, enterprise platforms, independent AI specialists and provider-origin businesses now compete for the same workflow, and the economics depend on whether new fees add to or replace existing ones.
  • 3. Recurring relationships carry more of the revenue. Subscriptions, committed usage and overages raise the importance of accepted billable activity, matched renewal pricing and retained paid modules.
  • 4. Modular entry can become a route to consolidation. A bounded viewer or workflow award can strengthen a supplier's position for the next archive decision.
  • 5. Managed hosting changes how growth should be read. Vendor receipts can increase as infrastructure responsibility moves into an application-service contract while the buyer's total operating cost moves differently.
  • 6. Delivery capacity sets the quality of growth. Wider contracts raise migration, support and integration obligations, so repeatable implementation becomes a competitive advantage.

Competitive Structure

Competition is organized into seven Competitive Clusters: enterprise imaging and diagnostic platform suppliers; locally integrated PACS/RIS and segment-focused suppliers; archive, interoperability, image access and common data workflow businesses; reporting, speech and reader-productivity suppliers; unified reader platforms and provider-origin technology businesses; AI orchestration, marketplace and governance platforms; and EHR, cloud and infrastructure adjacencies.

Each assessment covers the relevant buying decision, product and service scope, distribution position, implementation obligations and the conditions for retained payment. The report applies a Five Forces assessment and the GTM Growth–Maturity Matrix to selected participants. Coverage spans 62 company, business-unit, platform, historical-participant and adjacency spotlight entries, including Pro Medicus/Visage, Sectra, Agfa HealthCare, Fujifilm, Philips, GE HealthCare, Intelerad, Siemens Healthineers, Merge/Merative, Dedalus, INFINITT, Hyland, Mach7, Microsoft/Nuance, Rad AI, Sirona Medical, RadNet/DeepHealth, deepc, Incepto, CARPL.ai, Epic and Oracle Health.

What's Inside

Global market structure and outlook: Base, Bull and Bear scenarios with annual forecasts through 2036, by function, revenue-recognition stream and region.

Markintel® strategic frameworks: M³ Market Momentum Matrix, M-TEM Technology Evolution Matrix, T-DIC transition windows, Solution Adoption and Growth, Upgrade and Package Ladder, and Ecosystem Collaboration Matrix.

Company spotlights: 62 entries organized by Competitive Cluster, with cross-references and an alphabetical index.

Regional and country analysis: Five regions and 31 countries and analytical clusters, each tied to local purchasing, delivery and affordability conditions.

Commercialization and operating economics: Architecture choices, pricing references, minimums and overages, implementation acceptance, cloud procurement, reporting monetization and retention measures.

Strategic priorities: Sensitivities, signposts, priorities by Competitive Cluster and a staged 12–24-month action agenda.

Who Should Read This Report

  • Imaging-software, PACS and OEM executives and product leaders
  • Strategy, corporate-development and M&A teams
  • Investors and their advisors evaluating imaging IT businesses
  • Commercial and channel leaders planning market entry or account expansion
  • Health systems, radiology groups and imaging networks preparing platform, archive or reporting procurements
  • Consultants and advisory firms serving the imaging value chain

Why This Report

Few market studies separate new spending from transferred spending. This report does: it reconciles functional, recognition and geographic views to one revenue boundary, keeps clinical AI outside the core so totals are not double counted, and tests the assumptions that matter most to the conclusions. The company analysis is specific about the decision, buyer and geography behind each competitive claim, and the recommendations are staged so that larger commitments follow accepted deployment and retained payment.

Report Details

  • Title: Global Enterprise Imaging IT & PACS Horizon: Market Structure, Forecasts, Competitive Dynamics, and Workflow Monetization, 2025A–2036E
  • Report Type: Markintel® Horizon Report
  • Publisher: Marketstrat, Inc.
  • Publication Date: October 2026
  • Report ID: MINTH-02107
  • Base Year and Forecast Period: 2025A; 2025A–2036E
  • Length: 198 pages
  • Content: 97 tables and 34 figures
  • Format: PDF; Excel annual-data supplements available on request
  • Regional Coverage: North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
  • Country Coverage: 31 countries and analytical clusters
  • Competitive Coverage: 62 companies spotlighted across seven Competitive Clusters
  • License Options: Individual $4,750 | Team $5,250 | Enterprise $8,950
Product Code: MINTH-02107

Table of Contents

SECTION 1: EXECUTIVE SUMMARY

  • 1.1 EXECUTIVE VIEW
  • 1.2 WHERE MARKET GROWTH CONCENTRATES
    • Global functional outlook
  • 1.3 THE COMMERCIAL MODEL CHANGES WITH THE DELIVERY OBLIGATION
    • Recurring relationships carry more of the revenue
    • Consolidation can proceed through selected replacements
    • Reporting and hosting change the interpretation of growth
  • 1.4 COMPETITIVE OUTLOOK: SEVEN CLUSTERS, OVERLAPPING BUYING DECISIONS
    • Competitive landscape at a glance
  • 1.5 GEOGRAPHIC PRIORITIES: PROTECT SCALE AND QUALIFY EXPANSION LOCALLY
    • Regional market outlook
  • 1.6 SCENARIOS AND RISKS: EXECUTION DETERMINES HOW MUCH OPPORTUNITY BECOMES REVENUE
    • Global scenario outlook
  • 1.7 EXECUTIVE IMPLICATIONS AND ACTIONS
  • 1.8 SIGNALS TO WATCH OVER THE NEXT 12–24 MONTHS
  • 1.9 SCOPE AND CONFIDENCE IN THE ESTIMATES
  • 1.10 EXECUTIVE CONCLUSION

SECTION 2: RESEARCH SCOPE, DEFINITIONS, AND METHODOLOGY

  • 2.1 PURPOSE AND MARKET DEFINITION
  • 2.2 REVENUE BOUNDARIES AND COUNTING RULES
  • 2.3 HISTORICAL MARKET CONSTRUCTION
  • 2.4 COUNTRY ALLOCATION AND ANNUAL GROWTH
  • 2.5 CONTRACT ECONOMICS AND ACTIVATION
  • 2.6 FUNCTIONAL AND RECOGNITION-STREAM VIEWS
  • 2.7 AI OVERLAP AND SPENDING TRANSFER
  • 2.8 SCENARIOS AND UNCERTAINTY
  • 2.9 EVIDENCE HANDLING AND ANALYTICAL RESPONSIBILITY
  • 2.10 INTERPRETATION

SECTION 3: GLOBAL MARKET STRUCTURE AND OUTLOOK

  • 3.1 MARKET OUTLOOK
    • Global market scenarios
  • 3.2 CORE VIEWING AND ARCHIVES RETAIN THE LARGEST ABSOLUTE OPPORTUNITY
    • Global functional market
  • 3.3 REPORTING COMPETITION CAN REDISTRIBUTE EXISTING SPENDING
  • 3.4 RECURRING RECOGNITION BECOMES MORE IMPORTANT
    • Revenue by recognition stream
  • 3.5 GEOGRAPHIC SCALE AND GROWTH REQUIRE DIFFERENT COMMERCIAL PRIORITIES
  • 3.6 SENSITIVITIES IDENTIFY THE MOST CONSEQUENTIAL OPERATING EXPOSURES
  • 3.7 STRATEGIC IMPLICATIONS
  • 3.8 GLOBAL CONCLUSION
  • 3.9 STRATEGIC THESIS: THE RENEWAL DECISION DETERMINES ACCESS TO A WIDER REVENUE POOL
  • 3.10 FRAMEWORK ARCHITECTURE AND DECISION USE
  • 3.11 M³ MARKET MOMENTUM MATRIX: SCALE AND GROWTH POINT TO DIFFERENT COMMERCIAL ROLES
    • Functional momentum and contribution to growth
  • 3.12 M-TEM: MATURE TECHNOLOGY CAN STILL HAVE AN IMMATURE DELIVERY MODEL
  • 3.13 T-DIC: THREE CONDITIONAL TRANSITION WINDOWS
  • 3.14 SOLUTION ADOPTION AND GROWTH: MATCH THE SELLING MOTION TO THE BUYER’S ACTUAL TASK
  • 3.15 REVENUE CREATION AND DISPLACEMENT: A NECESSARY COMMERCIAL BRIDGE
  • 3.16 CLOUD CONTRACTS: DISTINGUISH SUPPLIER REVENUE FROM THE CUSTOMER’S OPERATING BILL
  • 3.17 MARKINTEL UPGRADE & PACKAGE LADDER: SEQUENCE COMMITMENTS AROUND READINESS
  • 3.18 ECOSYSTEM COLLABORATION: PARTNERSHIP VALUE DEPENDS ON OPERATING RESPONSIBILITY
  • 3.19 STRATEGIC ROBUSTNESS: ACTIONS THAT REMAIN USEFUL ACROSS THE SCENARIOS

SECTION 4: COMPETITIVE CLUSTERS, COMPANY SPOTLIGHTS AND COMMERCIAL STRATEGY

  • 4.1 COMPETITIVE THESIS: CONTROL IS DISTRIBUTED ACROSS THE IMAGING WORKFLOW
  • 4.2 COMPETITIVE CLUSTERS AND COMPANY COVERAGE
    • Competitive cluster map and covered participants
  • 4.3 HISTORICAL REVENUE SCALE: USEFUL CONTEXT, LIMITED RANKING PRECISION
    • Selected historical eligible-core revenue estimates
  • 4.4 WHY COMPETITIVE POSITIONS ARE DIFFICULT TO DISPLACE, AND WHERE ENTRY REMAINS POSSIBLE
  • 4.5 GTM GROWTH–MATURITY MATRIX: SELECTIVE COMPANY PLACEMENTS
    • Competitive dataset and placement rationale
    • Competitive context and growth–maturity highlights
  • 4.6 COMPETITIVE CLUSTER 1: ENTERPRISE IMAGING AND DIAGNOSTIC PLATFORM SUPPLIERS
    • 4.6.1 Pro Medicus / Visage: the reader environment supports expansion, but each module needs a paid decision
    • 4.6.2 Sectra: enterprise scope increases strategic influence and operating obligations
    • 4.6.3 Agfa HealthCare: the quality of conversion matters more than the cloud-order label
    • 4.6.4 Philips: a substantial informatics platform needs an imaging-specific commercial account
    • 4.6.5 Fujifilm: breadth and local position support scale, but revenue scope remains important
    • 4.6.6 GE HealthCare legacy imaging IT: continuity of the installed business remains a distinct commercial task
    • 4.6.7 Intelerad: an acquired application platform with its own operating history
    • 4.6.8 Siemens Healthineers: define the software objective independently of scanner relationships
    • 4.6.9 Merge: current cloud development prevents a simple incumbent-versus-cloud narrative
  • 4.7 COMPETITIVE CLUSTER 2: LOCALLY INTEGRATED PACS/RIS AND SEGMENT-FOCUSED SUPPLIERS
    • 4.7.1 Dedalus imaging IT: local workflow supports the enterprise relationship
    • 4.7.2 INFINITT: global application revenue requires a global competitive lens
    • 4.7.3 TechMatrix / PSP: cloud packaging changes the unit of purchase
    • 4.7.4 Telemis: local execution can preserve value in a broad platform market
    • 4.7.5 Neagen / Vitec: local imaging expertise and group scale are separate measures
    • 4.7.6 IMEXHS: the separation of software and professional reading is commercially decisive
    • 4.7.7 Konica Minolta imaging IT: integration and specialist partnerships coexist
    • 4.7.8 Canon Medical imaging IT: shared image management deserves separate treatment from specialty analysis
    • 4.7.9 RamSoft: a complete workflow proposition for defined operating environments
    • 4.7.10 Novarad: preserve the common-imaging perimeter within a broader portfolio
    • 4.7.11 CGM / VISUS: JiveX belongs in the imaging comparison independently of the parent EHR business
    • 4.7.12 NEXUS / CHILI: evaluate the imaging business at the application level
    • 4.7.13 Softway Medical imaging: distinguish the local imaging franchise from general hospital software
    • 4.7.14 Maincare: retained application and integration value must be separated from pass-through
    • 4.7.15 PaxeraHealth: breadth must become repeatable deployment
    • 4.7.16 IMAGE Information Systems: an application specialist can remain relevant in bounded replacements
    • 4.7.17 Neusoft imaging software: identify the software entity before interpreting scale
    • 4.7.18 Winning: a named local-supplier example with a deliberately limited financial claim
    • 4.7.19 B-Soft: local healthcare-IT context requires an imaging-specific boundary
    • 4.7.20 Xunfei imaging activity: identity and product scope remain bounded
    • 4.7.21 TechHeim: an identifiable Korean PACS participant without an inferred share
    • 4.7.22 Medsynaptic: alternative delivery configurations support a distinct commercialization model
    • 4.7.23 Pixeon: regional integration and modular imaging are relevant to Brazilian procurement
    • 4.7.24 MV imaging: integrated clinical software requires disciplined revenue allocation
    • 4.7.25 AKGUN imaging: interinstitutional capability should be separated from geographic revenue attribution
    • 4.7.26 Lifetrack Medical Systems: distributed reading requires a supportable application configuration
    • 4.7.27 BMD Software / PACScenter: web-based imaging spans provider and network configurations
  • 4.8 COMPETITIVE CLUSTER 3: ARCHIVE, INTEROPERABILITY, IMAGE ACCESS AND COMMON DATA WORKFLOW
    • 4.8.1 Hyland
    • 4.8.2 Mach7
    • 4.8.3 Optum / Change legacy imaging: continuity and ownership labels must not obscure product scope
    • 4.8.4 Enlitic common data workflow: difficult data work can remain valuable through platform replacement
    • 4.8.5 PocketHealth: access adoption and paid adoption have different denominators
  • 4.9 COMPETITIVE CLUSTER 4: REPORTING, SPEECH AND READER-PRODUCTIVITY SUPPLIERS
    • 4.9.1 Microsoft / Nuance: an active incumbent with a substantial reporting position
    • 4.9.2 Rad AI: independent reporting must retain value through incumbent response
    • 4.9.3 Solventum radiology reporting: a specialist perimeter inside a wider software business
    • 4.9.4 NewVue: reader operations can be sold through a platform partner
    • 4.9.5 New Lantern: distinguish the platform proposition from the evidence of paid scale
    • 4.9.6 RADPAIR: an identifiable reporting participant within the smaller-supplier pool
    • 4.9.7 nVoq: a speech-technology partner with a narrower role than the contracted imaging platform
  • 4.10 COMPETITIVE CLUSTER 5: UNIFIED READER PLATFORMS AND PROVIDER-ORIGIN TECHNOLOGY BUSINESSES
    • 4.10.1 Sirona: the international contract is strategically significant, while activation remains the test
    • 4.10.2 RadNet / DeepHealth: internal experience and external demand require separate accounts
    • 4.10.3 Mosaic / Radiology Partners: internal scale provides a development environment, not an external revenue total
  • 4.11 COMPETITIVE CLUSTER 6: AI ORCHESTRATION, MARKETPLACE AND GOVERNANCE PLATFORMS
    • 4.11.1 deepc: retained governance requires an operating proposition after integration
    • 4.11.2 Incepto: distribution and service economics must be separated from gross application resale
    • 4.11.3 CARPL.ai: catalog breadth needs a paid governance counterpart
    • 4.11.4 Ferrum Health: implementation evidence is useful only with the correct denominator
    • 4.11.5 Aidoc’s eligible platform activity: broader clinical reach is not the core-market denominator
    • 4.11.6 Bayer / Blackford: a historical case in platform durability
  • 4.12 COMPETITIVE CLUSTER 7: EHR, CLOUD AND INFRASTRUCTURE ADJACENCIES
    • 4.12.1 Epic: EHR workflow influences imaging procurement without defining the entire imaging contract
    • 4.12.2 Oracle Health: EHR adjacency and a marketed PACS offering require a dual treatment
    • 4.12.3 Amazon Web Services: infrastructure can shape the application economics without replacing the application
    • 4.12.4 Microsoft Azure: separate the infrastructure relationship from Nuance application revenue
    • 4.12.5 Google Cloud: interoperable data services are an enabling layer
  • 4.13 FIVE COMPETITIVE CASES THAT CHANGE COMMERCIAL INTERPRETATION
  • 4.14 COMPETITIVE POSITIONS THAT WOULD STRENGTHEN OR WEAKEN THE THESIS
  • 4.15 COMMERCIAL PRIORITIES BY PARTICIPANT
  • 4.16 A PRACTICAL COMPETITIVE DASHBOARD
  • 4.17 COMPETITIVE CONCLUSION

SECTION 5: REGIONAL AND COUNTRY MARKET ANALYSIS

  • 5.1 REGIONAL SCALE AND THE LOCAL MECHANISMS OF COMMERCIALIZATION
    • Regional market outlook
    • Absolute growth and the changing Asia-Pacific mix
    • How to interpret the country analysis
    • Regional commercialization archetypes
  • 5.2 NORTH AMERICA
    • Regional scenario reference
    • 5.2.1 United States
    • 5.2.2 Canada
  • 5.3 EUROPE
    • 5.3.1 Germany
    • 5.3.2 France
    • 5.3.3 United Kingdom
    • 5.3.4 Italy
    • 5.3.5 Spain
    • 5.3.6 Republic of Ireland
    • 5.3.7 Nordics
    • 5.3.8 Benelux
    • 5.3.9 Central / Eastern Europe
    • 5.3.10 Rest of Europe
  • 5.4 ASIA-PACIFIC
    • Regional scenario reference
    • 5.4.1 Mainland China
    • 5.4.2 Japan
    • 5.4.3 India
    • 5.4.4 South Korea
    • 5.4.5 Australia
    • 5.4.6 New Zealand
    • 5.4.7 Singapore / Taiwan
    • 5.4.8 Southeast Asia ex-Singapore
    • 5.4.9 South Asia ex-India
    • 5.4.10 Other Asia-Pacific
  • 5.5 LATIN AMERICA
    • Regional scenario reference
    • 5.5.1 Brazil
    • 5.5.2 Mexico
    • 5.5.3 Rest of Latin America
  • 5.6 MIDDLE EAST & AFRICA
    • Regional scenario reference
    • 5.6.1 Saudi Arabia
    • 5.6.2 United Arab Emirates
    • 5.6.3 Rest of GCC
    • 5.6.4 South Africa
    • 5.6.5 North Africa
    • 5.6.6 Rest of Middle East / Africa
  • 5.7 CROSS-REGIONAL STRATEGIC SYNTHESIS
    • Image availability and application replacement must be evaluated separately
    • Local suppliers change the attainable package, not merely the headline price
    • Scale and growth require a two-part resource decision
    • Evidence that would change the geographic interpretation
  • 5.8 GEOGRAPHIC CONCLUSION

SECTION 6: TECHNOLOGY, COMMERCIALIZATION AND OPERATING ECONOMICS

  • 6.1 COMMERCIAL THESIS: THE DELIVERY OBLIGATION DETERMINES THE QUALITY OF GROWTH
  • 6.2 ARCHITECTURE SELECTION SHOULD START WITH THE REPLACEMENT BOUNDARY
    • Architecture choice and the obligation it creates
  • 6.3 BUYER-SPECIFIC CONFIGURATIONS DETERMINE THE SELLING MOTION
  • 6.4 PRICING REFERENCES NEED A COMMON SCOPE BEFORE THEY BECOME BENCHMARKS
    • Selected contract references and their interpretation
  • 6.5 MINIMUMS AND OVERAGES ALLOCATE DEMAND RISK
  • 6.6 FOUR COMMERCIAL CLOCKS EXPLAIN WHY CONTRACT VALUE AND REVENUE DIFFER
  • 6.7 IMPLEMENTATION SHOULD BE MANAGED AS A PORTFOLIO OF ACCEPTED WORKLOADS
    • Recommended implementation acceptance schedule
  • 6.8 CLOUD PROCUREMENT NEEDS TWO ECONOMIC SCHEDULES
    • Match the buyer obligation to the supplier obligation
  • 6.9 REPORTING MONETIZATION REQUIRES A POST-TRANSITION SPENDING TEST
  • 6.10 PAID-MODULE ATTACHMENT SHOULD BE EVALUATED AT RENEWAL
  • 6.11 INDEPENDENT ORCHESTRATION NEEDS A FUNDED CONTINUING ROLE
  • 6.12 INTEROPERABILITY, SERVICE CONTINUITY AND GOVERNANCE HAVE CONTRACT-LEVEL CONSEQUENCES
  • 6.13 RETENTION AND UNIT ECONOMICS SHOULD BE ASSESSED ON A MATCHED CUSTOMER BASE
    • Proposed measures for operating review
  • 6.14 COMMERCIALIZATION PRIORITIES BY COMPETITIVE CLUSTER
  • 6.15 SECTION CONCLUSION

SECTION 7: SCENARIO OUTLOOK, STRATEGIC PRIORITIES AND ACTION AGENDA

  • 7.1 STRATEGIC THESIS: PACE COMMITMENTS AGAINST THE CONDITIONS REQUIRED FOR REVENUE
    • Global market scenarios
  • 7.2 THE SCENARIOS CHANGE OPERATING CONDITIONS, NOT THE HISTORICAL DENOMINATOR
    • Principal operating assumptions that distinguish the scenarios
    • 7.3 BASE CASE: COORDINATED EXECUTION CREATES A LARGER RECURRING MARKET
    • 7.4 BULL CASE: FASTER IMPLEMENTATION MUST COINCIDE WITH RETAINED MONETIZATION
    • 7.5 BEAR CASE: A MARKET CAN GROW WHILE EXPANSION ECONOMICS DETERIORATE
    • 7.6 SENSITIVITIES IDENTIFY ECONOMIC EXPOSURE, NOT PROBABILITIES
  • Terminal sensitivity to selected operating changes
  • 7.7 FUNCTIONAL EXPOSURE CONCENTRATES IN BOTH CORE APPLICATIONS AND EXPANSION CATEGORIES
    • Functional distribution of the 2036 scenario spread
    • 7.8 GEOGRAPHIC EXPOSURE SEPARATES ABSOLUTE SCALE FROM RELATIVE DISPERSION
  • Regional distribution of the 2036 scenario spread
  • 7.9 OBSERVABLE SIGNPOSTS SHOULD BE TIED TO THE PARAMETER THEY CAN CHANGE
    • Evidence-to-decision monitoring schedule
    • 7.10 STRATEGIC PRIORITIES BY COMPETITIVE CLUSTER
    • 7.11 BUYER AND CORPORATE-DEVELOPMENT PRIORITIES
    • 7.12 A STAGED 12–24-MONTH ACTION AGENDA
    • 7.13 RISK BOUNDARIES AND INTERPRETATION LIMITS
    • 7.14 FINAL STRATEGIC CONCLUSION

APPENDIX A: REVENUE DEFINITIONS AND REPORTING CONVENTIONS

  • A.1 PURPOSE AND MARKET BOUNDARY
  • A.2 FUNCTIONAL DEFINITIONS
  • A.3 REVENUE-RECOGNITION DEFINITIONS
  • A.4 COUNTING AND COMPARABILITY RULES
  • A.5 UNITS, YEARS AND CURRENCY
  • A.6 FORMULA AND DENOMINATOR REFERENCE

APPENDIX B: GEOGRAPHIC COVERAGE AND MEMBERSHIP

  • B.1 GEOGRAPHIC ALLOCATION
  • B.2 COUNTRY AND CLUSTER MEMBERSHIP
  • B.3 BOUNDARY CONVENTIONS THAT AFFECT COMPARISON
  • B.4 HISTORICAL ALLOCATION AND UNCERTAINTY

APPENDIX C: SELECTED ASSUMPTIONS, SCENARIO DESIGN AND EVIDENCE LIMITS

  • C.1 HISTORICAL MEASUREMENT BASIS
  • C.2 FORECAST STRUCTURE AND SELECTED COMMON CONVENTIONS
  • C.3 COUNTRY ASSUMPTIONS RETAINED IN THE FORECAST
  • C.4 SCENARIO ASSUMPTIONS
  • C.5 TERMINAL SENSITIVITIES ARE A DIFFERENT TEST
  • C.6 EVIDENCE AND INTERPRETATION LIMITS
  • C.7 STATUS OF STATEMENTS AND CALCULATIONS

APPENDIX D: ANNUAL FORECASTS AND DATA-COMPANION GUIDE

  • D.1 GLOBAL ANNUAL SCENARIOS
  • D.2 COVERAGE OF THE ANNUAL DATA COMPANION
  • D.3 HOW TO USE THE TABLES
  • D.4 DATA DICTIONARY AND EMPTY VALUES

APPENDIX E: COMPANY AND BUSINESS INDEX

  • E.1 HOW TO USE THIS INDEX
  • E.2 COMPETITIVE CLUSTER REFERENCE
  • E.3 ALPHABETICAL COMPANY/BUSINESS INDEX
  • E.4 ENTITY, OWNERSHIP AND SCOPE CONVENTIONS

APPENDIX F: FRAMEWORK INTERPRETATION AND COMMERCIAL TERMINOLOGY

  • F.1 FRAMEWORK READING GUIDE
  • F.2 COMMERCIAL TERMINOLOGY
  • F.3 INTERPRETATION OF VISUAL FORMS
  • F.4 COMMERCIAL MONITORING DEFINITIONS
Product Code: MINTH-02107

List of Tables

  • TABLE 1: GLOBAL ENTERPRISE IMAGING IT & PACS REVENUE BY FUNCTION, 2025A AND 2036E (BASE CASE, US$ MILLION)
  • TABLE 2: ENTERPRISE IMAGING IT & PACS COMPETITIVE LANDSCAPE: EXECUTIVE CLUSTER SUMMARY
  • TABLE 3: REGIONAL ENTERPRISE IMAGING IT & PACS REVENUE AND GROWTH CONTRIBUTIONS, 2025A–2036E (BASE CASE, US$ MILLION)
  • TABLE 4: GLOBAL ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS AND OPERATING CONDITIONS, 2025A–2036E (US$ BILLION)
  • TABLE 5: EXECUTIVE PRIORITIES AND CONDITIONS FOR LARGER COMMITMENTS BY STAKEHOLDER
  • TABLE 6: GLOBAL ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E (US$ BILLION)
  • TABLE 7: ATTRIBUTION OF THE MODELED GLOBAL REVENUE INCREASE, 2025A–2036E
  • TABLE 8: GLOBAL ENTERPRISE IMAGING IT & PACS REVENUE BY FUNCTION, 2025A, 2030E AND 2036E (BASE CASE; US$ MILLION)
  • TABLE 9: GLOBAL ENTERPRISE IMAGING IT & PACS REVENUE BY RECOGNITION STREAM, 2025A, 2030E AND 2036E (US$ MILLION; BASE CASE)
  • TABLE 10: GLOBAL ENTERPRISE IMAGING IT & PACS REVENUE BY REGION, 2025A, 2030E AND 2036E (US$ MILLION; BASE CASE)
  • TABLE 11: MARKINTEL® STRATEGIC FRAMEWORKS: DECISION USES, ANALYTICAL BASES AND INTERPRETATION LIMITS
  • TABLE 12: M³ MARKET MOMENTUM MATRIX: FUNCTIONAL SCALE, GROWTH AND POSITIONING, 2025A–2036E (US$ MILLION; BASE CASE)
  • TABLE 13: FUNCTIONAL REVENUE GROWTH BY SCENARIO, 2025A–2036E
  • TABLE 14: FUNCTIONAL ALLOCATION SENSITIVITY AT AN UNCHANGED GLOBAL MARKET, 2036E
  • TABLE 15: M-TEM TECHNOLOGY EVOLUTION MATRIX: CAPABILITY MATURITY AND COMMERCIAL CONSTRAINTS
  • TABLE 16: T-DIC: CONDITIONAL TECHNOLOGY AND COMMERCIALIZATION TRANSITIONS, 2026–2036
  • TABLE 17: SOLUTION ADOPTION & GROWTH: USE-CASE POSITIONING AND COMMERCIAL TESTS
  • TABLE 18: CLOUD CONTRACT COMPARISON: SCOPE, OPERATING RESPONSIBILITIES AND ECONOMICS
  • TABLE 19: UPGRADE & PACKAGE LADDER: SCOPE, READINESS AND COMMERCIAL DISCIPLINE
  • TABLE 20: ECOSYSTEM COLLABORATION MATRIX: RELATIONSHIP TYPES, STRATEGIC VALUE AND OPERATING TESTS
  • TABLE 21: SCENARIO-RESILIENT PRIORITIES AND CONDITIONS FOR LARGER COMMITMENTS
  • TABLE 22: ENTERPRISE IMAGING IT & PACS COMPETITIVE CLUSTERS AND COMPANY COVERAGE
  • TABLE 23: SELECTED SUPPLIER COMMON-IMAGING REVENUE ESTIMATES AND JUDGMENTAL RANGES, 2025A US$ MILLION; ALPHABETICAL PRESENTATION
  • TABLE 24: FIVE FORCES IN ENTERPRISE IMAGING IT & PACS: ASSESSMENT AND COMMERCIAL IMPLICATIONS
  • TABLE 25: GTM GROWTH–MATURITY MATRIX: SELECTED COMPANY PLACEMENTS, EVIDENCE AND COUNTERWEIGHTS
  • TABLE 26: FIVE COMPETITIVE CASES: SUPPORTED INTERPRETATIONS AND STRATEGIC CONSEQUENCES
  • TABLE 27: COMPETITIVE THESIS TESTS: EVIDENCE THAT WOULD STRENGTHEN OR WEAKEN CURRENT JUDGMENTS
  • TABLE 28: COMPETITIVE MONITORING DASHBOARD: PROPOSED MEASURES, DEFINITIONS AND INTERPRETATION ERRORS
  • TABLE 29: REGIONAL ENTERPRISE IMAGING IT & PACS REVENUE OUTLOOK AND GLOBAL GROWTH CONTRIBUTIONS, 2025A– 2036E (US$ MILLION; BASE CASE)
  • TABLE 30: TOP FIVE COUNTRY AND CLUSTER CONTRIBUTIONS TO GLOBAL REVENUE GROWTH, 2025A–2036E (BASE CASE)
  • TABLE 31: REGIONAL COMMERCIALIZATION ARCHETYPES: ESTABLISHED REVENUE POOLS AND COVERAGE EXPANSION
  • TABLE 32: NORTH AMERICA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 33: UNITED STATES ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 34: CANADA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 35: EUROPE ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 36: GERMANY ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 37: FRANCE ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 38: UNITED KINGDOM ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 39: ITALY ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 40: SPAIN ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 41: REPUBLIC OF IRELAND ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 42: NORDICS ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 43: BENELUX ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 44: CENTRAL/EASTERN EUROPE ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 45: REST OF EUROPE ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 46: ASIA-PACIFIC ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 47: MAINLAND CHINA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 48: JAPAN ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 49: INDIA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 50: SOUTH KOREA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 51: AUSTRALIA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 52: NEW ZEALAND ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 53: SINGAPORE/TAIWAN ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 54: SOUTHEAST ASIA EX-SINGAPORE ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 55: SOUTH ASIA EX-INDIA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 56: OTHER ASIA-PACIFIC ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 57: LATIN AMERICA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 58: BRAZIL ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 59: MEXICO ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 60: REST OF LATIN AMERICA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 61: MIDDLE EAST & AFRICA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 62: SAUDI ARABIA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 63: UNITED ARAB EMIRATES ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 64: REST OF GCC ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 65: SOUTH AFRICA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 66: NORTH AFRICA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 67: REST OF MIDDLE EAST / AFRICA ENTERPRISE IMAGING IT & PACS REVENUE SCENARIOS, 2025A–2036E, US$ MILLION
  • TABLE 68: GEOGRAPHIC FORECAST SIGNPOSTS: OBSERVATIONS, INTERPRETATIONS AND REVISION DISCIPLINE
  • TABLE 69: ARCHITECTURE CHOICES: BUYER PROBLEMS, OPERATING OBLIGATIONS AND ACCEPTANCE TESTS
  • TABLE 70: BUYER-SPECIFIC COMMERCIAL CONFIGURATIONS AND CONDITIONS FOR PAID EXPANSION
  • TABLE 71: SELECTED IMAGING-IT CONTRACTS: COMMITMENTS, TERMS AND ANNUALIZED REFERENCES
  • TABLE 72: IMPLEMENTATION ACCEPTANCE FRAMEWORK: DELIVERABLES, EVIDENCE AND COMMERCIAL CONSEQUENCES
  • TABLE 73: CLOUD OPERATING ECONOMICS: MATCHED BUYER AND SUPPLIER RESPONSIBILITIES
  • TABLE 74: PROPOSED RETENTION AND UNIT-ECONOMICS MEASURES FOR OPERATING REVIEW
  • TABLE 75: COMMERCIALIZATION PRIORITIES AND CONDITIONS FOR EXPANSION BY COMPETITIVE CLUSTER
  • TABLE 76: GLOBAL ENTERPRISE IMAGING IT & PACS SCENARIOS AND TERMINAL DIFFERENCES FROM BASE, 2025A–2036E, US$ BILLION
  • TABLE 77: PRINCIPAL OPERATING ASSUMPTIONS BY SCENARIO
  • TABLE 78: ONE-AT-A-TIME SENSITIVITY OF GLOBAL REVENUE TO SELECTED OPERATING CHANGES, US$ MILLION, EXCEPT PERCENTAGES
  • TABLE 79: FUNCTIONAL REVENUE SCENARIOS AND CONTRIBUTIONS TO THE BULL–BEAR SPREAD, 2036E, US$ MILLION
  • TABLE 80: REGIONAL REVENUE SCENARIOS AND ABSOLUTE AND RELATIVE DISPERSION, 2036E
  • TABLE 81: FORECAST MONITORING: REQUIRED EVIDENCE AND THE ASSUMPTIONS IT CAN CHANGE
  • TABLE 82: STRATEGIC PRIORITIES, CONDITIONAL COMMITMENTS AND RISKS BY COMPETITIVE CLUSTER
  • TABLE 83: RECOMMENDED 12–24-MONTH ACTION AGENDA: DECISIONS, RESPONSIBILITIES AND EVIDENCE
  • TABLE 84: COMMON-IMAGING FUNCTIONAL DEFINITIONS AND SCOPE BOUNDARIES
  • TABLE 85: REVENUE-RECOGNITION STREAM DEFINITIONS AND INTERPRETATION
  • TABLE 86: REVENUE COUNTING AND COMPARABILITY RULES
  • TABLE 87: FORMULA AND DENOMINATOR REFERENCE: DEFINITIONS AND INTERPRETATION LIMITS
  • TABLE 88: GEOGRAPHIC COVERAGE: COUNTRY AND CLUSTER MEMBERSHIP AND BOUNDARIES
  • TABLE 89: SELECTED COUNTRY AND CLUSTER ASSUMPTIONS: STUDY GROWTH, PAID COVERAGE AND RENEWAL EXPOSURE
  • TABLE 90: SCENARIO ASSUMPTIONS: DEMAND, CONVERSION, PRICING, MODULES AND SERVICE PARAMETERS
  • TABLE 91: EVIDENCE LIMITATIONS AND REQUIRED INTERPRETATION BY ANALYTICAL AREA
  • TABLE 92: GLOBAL ENTERPRISE IMAGING IT & PACS ANNUAL REVENUE SCENARIOS, 2025A–2036E, US$ BILLION
  • TABLE 93: ANNUAL DATA COMPANION: FORECAST SCHEDULE COVERAGE AND OBSERVATION COUNTS
  • TABLE 94: COMPETITIVE CLUSTER DEFINITIONS AND SPOTLIGHT COUNTS
  • TABLE 95: COMPANY AND BUSINESS INDEX: PRINCIPAL COMPETITIVE CLUSTER AND SPOTLIGHT LOCATION
  • TABLE 96: MARKINTEL FRAMEWORK READING GUIDE: DIMENSIONS, APPLICATIONS AND INTERPRETATION LIMITS
  • TABLE 97: ENTERPRISE IMAGING IT & PACS COMMERCIAL GLOSSARY

List of Figures

  • FIGURE 1: FASTER EXPANSION DOES NOT DISPLACE THE CORE
  • FIGURE 2: RECURRING MIX DEPENDS ON THE ALLOCATION CONVENTION
  • FIGURE 3: DIFFERENT GROWTH ROUTES FACE THE SAME PROOF TEST
  • FIGURE 4: SCALE AND LOCAL DELIVERY SET GEOGRAPHIC PRIORITIES
  • FIGURE 5: ONE REVENUE BOUNDARY, SEVERAL MARKET VIEWS
  • FIGURE 6: COUNTRY ALLOCATION PRESERVES THE RAW BUYER ESTIMATE
  • FIGURE 7: FUNCTIONAL CONTRIBUTIONS TO GLOBAL MARKET GROWTH
  • FIGURE 8: FUNCTIONAL MOMENTUM DEPENDS ON ALLOCATION
  • FIGURE 9: TECHNICAL MATURITY CAN EXCEED DELIVERY READINESS
  • FIGURE 10: COMMERCIAL IMPACT DEPENDS ON REPEATABLE DELIVERY
  • FIGURE 11: PAID SCOPE MUST SURVIVE ACTIVATION AND RENEWAL
  • FIGURE 12: EVERY UPGRADE REQUIRES NEW OPERATING PROOF
  • FIGURE 13: PARTNERSHIP VALUE DEPENDS ON OPERATING RESPONSIBILITY
  • FIGURE 14: SEVEN CLUSTERS MEET AT THE BUYER’S NEXT DECISION
  • FIGURE 15: BROAD REVENUE RANGES LIMIT SUPPLIER RANKINGS
  • FIGURE 16: GROWTH AND EXECUTION CREATE DIFFERENT POSITIONS
  • FIGURE 17: FOUR ROUTES COMPETE FOR THE READER RELATIONSHIP
  • FIGURE 18: A PARTIAL AWARD CAN BECOME A FULL-STACK CONTRACT
  • FIGURE 19: FAST GROWTH IS NOT THE SAME AS LARGE OPPORTUNITY
  • FIGURE 20: US SCALE DOMINATES; CANADIAN BUYING STAYS DISTINCT
  • FIGURE 21: EUROPE’S GROWTH EXTENDS BEYOND ITS LARGEST MARKET
  • FIGURE 22: INDIA AND SOUTHEAST ASIA GAIN ASIA-PACIFIC SHARE
  • FIGURE 23: BRAZIL ANCHORS GROWTH; LOCAL DELIVERY SHAPES ACCESS
  • FIGURE 24: GULF MARKETS ANCHOR A DIVERSE MEA OPPORTUNITY
  • FIGURE 25: SHARED IMAGE ACCESS NEED NOT REPLACE THE PACS
  • FIGURE 26: MINIMUMS PROTECT RECEIPTS; OVERAGES ADD ABOVE THE FLOOR
  • FIGURE 27: A CONTRACT HAS FOUR CLOCKS, NOT ONE REVENUE DATE
  • FIGURE 28: VENDOR GROWTH AND BUYER COSTS ARE DIFFERENT QUESTIONS
  • FIGURE 29: REPORTING CAN MOVE RECEIPTS WITHOUT MARKET GROWTH
  • FIGURE 30: RETAINED PLATFORM FEES MUST FUND THE OPERATING ROLE
  • FIGURE 31: EXECUTION SEPARATES THE THREE GROWTH PATHS
  • FIGURE 32: SENSITIVITY DEPENDS ON THE OPERATING CHANGE TESTED
  • FIGURE 33: ALLOCATION CHANGES WHERE SCENARIO DISPERSION SITS
  • FIGURE 34: PROTECT THE BASE; MAKE EXPANSION CONDITIONAL
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!